Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1261Question →

A 7272-year-old female is evaluated for discharge on hospital day 88. She was originally admitted for ischemic colitis complicated by bowel perforation, requiring an emergent laparotomy and the creation of a temporary colostomy. Her postoperative course was initially complicated by acute kidney injury that required 22 sessions of hemodialysis. However, her renal function has steadily improved, and hemodialysis was discontinued 44 days ago. Her current serum creatinine is 1.41.4 mg/dL (baseline 1.11.1 mg/dL). She is hemodynamically stable, afebrile, and tolerating a soft diet.

The patient is eager to return home. Prior to admission, she was fully independent with her activities of daily living and enjoyed gardening. She lives in a single-story home with her 7575-year-old husband, who has severe macular degeneration and is legally blind.

A physical therapy evaluation reveals she requires moderate assistance to transfer from the bed to a chair and can ambulate 1515 feet with a walker before requiring a seated rest. She reports severe fatigue after 3030 minutes of physical exertion. A nursing assessment notes that while the patient understands the steps of ostomy care, she currently lacks the manual dexterity and stamina to independently empty or change the appliance.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Discharge to a skilled nursing facility

Answer

Discharge to a skilled nursing facility
The correct answer is discharge to a skilled nursing facility (SNF). This patient has stabilized from her acute medical issues (ischemic colitis, acute kidney injury) and is ready for transition from the acute care hospital. However, she has significant functional deficits, requiring moderate assistance with transfers, and new skilled nursing needs (ostomy care). Her husband's visual impairment and age make a home discharge unsafe, as he cannot assist with physical transfers or appliance changes. Furthermore, her severe fatigue after 3030 minutes of activity disqualifies her from an Inpatient Rehabilitation Facility (IRF), which mandates the ability to participate in at least 33 hours of intensive therapy daily. An SNF is the optimal setting because it provides 2424-hour skilled nursing care for her ostomy and subacute physical therapy tailored to her lower endurance level.

Step-by-Step Solution

1
Evaluate the patient's current medical stability.
The patient is hemodynamically stable, tolerating a diet, and her acute kidney injury is recovering off dialysis.
This confirms she no longer requires acute inpatient hospitalization or a long-term acute care hospital (LTACH).
2
Assess rehabilitation potential and physical endurance.
She requires moderate assistance and fatigues rapidly after 30 minutes of exertion.
This determines the appropriate intensity of post-acute therapy. An Inpatient Rehabilitation Facility (IRF) requires tolerating 3 hours of daily therapy, which she cannot meet.
3
Analyze social determinants and home safety.
She lives with a legally blind, elderly husband who cannot safely assist with physical transfers or complex nursing tasks like ostomy care.
This confirms that discharging home with intermittent home health is unsafe due to the lack of 24-hour caregiver support.
4
Synthesize findings to select the optimal disposition setting.
The patient needs daily skilled nursing for her new ostomy and rehabilitative therapy, but has low endurance and an unsafe home environment.
A skilled nursing facility (SNF) provides subacute rehabilitation and 24-hour nursing support, perfectly matching her clinical profile.

Key Concept

Determining the appropriate post-acute care setting requires synthesizing the patient's medical stability, functional endurance limits (such as the ability to tolerate 3 hours of therapy for an IRF), and the physical capability of in-home caregivers to ensure safe transitions.
Question 1262Question →

A 54-year-old male presents to the emergency department with severe right groin pain that began 8 hours ago. He has a known right inguinal hernia that he usually pushes back in manually, but he has been unable to do so today. He reports nausea and two episodes of bilious emesis. Temperature is 38.4°C (101.1°F), blood pressure is 105/65 mm Hg, pulse is 118/min, and respirations are 18/min. Physical examination reveals a 6-cm bulge in the right inguinal region that is exquisitely tender to palpation, erythematous, and warm to the touch. The overlying skin is tense, and bowel sounds are absent over the mass. Laboratory studies show a leukocyte count of 16,500/mm³. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Emergent surgical exploration

Answer

The most appropriate next step is emergent surgical exploration.
The correct answer is emergent surgical exploration. This patient presents with a classic clinical picture of a strangulated inguinal hernia. While an incarcerated hernia is simply irreducible, a strangulated hernia involves compromised blood flow to the herniated contents (usually bowel or omentum), leading to ischemia and necrosis. Clinical hallmarks of strangulation include severe, exquisite tenderness, overlying skin erythema and warmth, fever, tachycardia, and leukocytosis. When a strangulated hernia is suspected clinically, the standard of care is immediate operative intervention to evaluate the viability of the trapped bowel and relieve the obstruction. Delaying surgery for imaging or attempting reduction dramatically increases morbidity and mortality.

Step-by-Step Solution

1
Identify the primary clinical problem from the patient's history and physical examination.
The patient has a painful, irreducible right inguinal hernia accompanied by systemic symptoms (fever, tachycardia, leukocytosis) and local inflammatory changes (erythema, warmth, exquisite tenderness).
Recognizing the transition from an incarcerated hernia to a strangulated hernia is critical for determining the urgency of intervention.
2
Evaluate the need for further diagnostic testing versus immediate intervention.
The diagnosis of a strangulated hernia is made clinically based on the presence of systemic toxicity and overlying skin changes. No further imaging is required.
Obtaining imaging in the setting of clear clinical signs of strangulation wastes valuable time and increases the risk of bowel perforation, sepsis, and death.
3
Select the most appropriate definitive management strategy.
The patient must be taken directly to the operating room for emergent surgical exploration.
Operative exploration allows for evaluation of bowel viability, resection of necrotic segments if necessary, and repair of the hernia defect.

Key Concept

Management of Strangulated Inguinal Hernias
Estimated Time:1m 0s
Question 1263Question →

A 72-year-old man comes to the clinic for a routine follow-up visit. He was recently diagnosed with highly symptomatic paroxysmal atrial fibrillation. Attempts to control his rhythm with metoprolol and flecainide were unsuccessful due to poor tolerance, and he was transitioned to amiodarone 4 weeks ago. His other medical conditions include hypertension and hyperlipidemia. His current medications are metoprolol, apixaban, atorvastatin, and amiodarone. The patient feels well and reports no further palpitations, shortness of breath, or muscle aches. His pulse is 62/min and regular, and blood pressure is 128/78 mm Hg. Physical examination reveals clear lungs, a regular cardiac rhythm, and no peripheral edema. Which of the following diagnostic tests are indicated for the routine periodic surveillance of this patient's new antiarrhythmic therapy? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Serum thyroid-stimulating hormone; Serum aminotransferases; Chest radiography

Answer

The correct tests for routine monitoring are serum thyroid-stimulating hormone, serum aminotransferases, and chest radiography.
The correct diagnostic tests are serum thyroid-stimulating hormone, serum aminotransferases, and chest radiography. Amiodarone is a highly effective, iodine-rich antiarrhythmic medication with a high volume of distribution and a long half-life. It is associated with significant, time-dependent toxicity in multiple organ systems. To detect these adverse effects early, mandatory routine surveillance is indicated even in asymptomatic patients. Specifically, thyroid-stimulating hormone (TSH) should be evaluated at baseline and every 3 to 6 months to detect hypo- or hyperthyroidism. Serum aminotransferases must be checked at baseline and every 6 months to monitor for hepatotoxicity. Finally, a baseline chest radiograph and annual follow-up imaging are required to screen for insidious pulmonary toxicity, such as chronic interstitial pneumonitis.

Step-by-Step Solution

1
Identify the primary medication of concern and its adverse effect profile.
The patient was recently started on amiodarone, a class III antiarrhythmic known for significant multi-organ toxicity.
Recognizing the drug's safety profile dictates the long-term surveillance strategy.
2
Determine the standard monitoring parameters recommended for this medication.
Guidelines mandate baseline and periodic monitoring of thyroid function (TSH every 3-6 months), hepatic function (aminotransferases every 6 months), and pulmonary status (annual chest radiography).
These organs are the most common sites of severe, potentially irreversible amiodarone toxicity.
3
Evaluate the patient's other medications for interactions that might require additional routine testing.
The patient takes apixaban and atorvastatin. While amiodarone interacts with atorvastatin, asymptomatic patients do not require routine creatine kinase screening. Apixaban does not require coagulation monitoring.
Ruling out unnecessary tests avoids over-investigation and misinterpretation of the coagulation cascade and pharmacokinetic interactions.

Key Concept

Routine monitoring for patients on amiodarone therapy requires periodic evaluation of thyroid function (TSH), hepatic function (aminotransferases), and pulmonary status (chest radiography) due to the drug's multi-organ toxicity profile.
Estimated Time:1m 30s
Question 1264Question →

A 7474-year-old female is evaluated in the emergency department for severe shortness of breath, confusion, and lethargy that has progressively worsened over the past 4848 hours. The patient has a known medical history of ischemic cardiomyopathy with a left ventricular ejection fraction of 20%20\%, chronic kidney disease stage 33, and type 22 diabetes mellitus. Her home medications include sacubitril-valsartan, carvedilol, spironolactone, empagliflozin, and aspirin.

Upon arrival, she is difficult to arouse but oriented to person only. Her extremities are cool and mottled, with weak distal pulses and delayed capillary refill. Jugular venous distention is prominent, estimated at 1212 cm H2OH_2O. Auscultation of the lungs reveals diffuse bilateral crackles extending to the apices. Cardiac examination reveals tachycardia with a regular rhythm and a distinct S3S_3 gallop.

Initial vital signs are:
Blood pressure: 78/5278/52 mm Hg
Heart rate: 118118/min
Respiratory rate: 2828/min
Oxygen saturation: 84%84\% on room air

Point-of-care laboratory testing reveals:
Serum creatinine: 3.43.4 mg/dL (baseline 1.61.6 mg/dL)
Serum potassium: 5.45.4 mEq/L
Venous lactate: 5.25.2 mmol/L

The patient is immediately placed on noninvasive positive pressure ventilation. The physician is preparing the initial pharmacologic management plan.

Which of the following interventions are appropriate for this patient at this time? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiate an intravenous dobutamine infusion; Discontinue home carvedilol therapy; Discontinue home sacubitril-valsartan therapy

Answer

The appropriate interventions are to initiate an intravenous dobutamine infusion, discontinue home carvedilol therapy, and discontinue home sacubitril-valsartan therapy.
The correct interventions are initiating an intravenous dobutamine infusion, discontinuing carvedilol, and discontinuing sacubitril-valsartan. This patient is presenting with cardiogenic shock, characterized by severe hypotension, signs of end-organ hypoperfusion (altered mental status, elevated lactate, acute kidney injury), and clinically evident volume overload (pulmonary edema, elevated jugular venous pressure, S3S_3 gallop). Inotropic support, such as dobutamine (a beta-1 agonist), is indicated to augment myocardial contractility and increase cardiac output, thereby restoring tissue perfusion. Simultaneously, negative inotropic agents like carvedilol must be discontinued immediately, as they severely compromise compensatory mechanisms in acute heart failure. Furthermore, sacubitril-valsartan must be held due to the presence of profound hypotension, acute kidney injury, and hyperkalemia; continuing it would further diminish renal perfusion and worsen shock.

Step-by-Step Solution

1
Assess the patient's hemodynamic and volume status based on clinical presentation.
The patient has signs of profound systemic hypoperfusion (hypotension, lactic acidosis, altered mental status, mottled extremities) and volume overload (elevated JVP, pulmonary crackles).
Identifying the specific shock phenotype (cardiogenic shock) is essential for selecting the correct resuscitative pathway.
2
Evaluate the current home medication list against the patient's acute physiologic derangements.
Carvedilol (negative inotrope) and sacubitril-valsartan (vasodilator, nephrotoxin in AKI) are acutely contributing to hypotension and organ hypoperfusion.
Deprescribing harmful medications is a critical pharmacologic intervention in critically ill patients.
3
Select appropriate pharmacologic interventions to restore perfusion and avoid contraindications.
Inotropic support (dobutamine) should be initiated. Intravenous fluids and vasodilators (nitroglycerin) must be avoided.
Dobutamine increases cardiac output, whereas fluids worsen pulmonary edema and vasodilators worsen shock.

Key Concept

Management of cardiogenic shock involves providing immediate inotropic support while simultaneously holding negative inotropes (beta-blockers) and therapies that exacerbate hypotension or acute kidney injury (renin-angiotensin system inhibitors).
Estimated Time:2m 0s
Question 1265Question →

A 24-year-old man with type 1 diabetes mellitus is admitted to the intensive care unit for the management of diabetic ketoacidosis precipitated by viral gastroenteritis. He has been receiving aggressive intravenous fluid resuscitation, potassium supplementation, and a continuous regular insulin infusion. Eighteen hours after admission, he is alert, reports feeling hungry, and has no nausea. Current laboratory studies show a serum glucose of 165 mg/dL165 \text{ mg/dL}, a serum bicarbonate of 18 mEq/L18 \text{ mEq/L}, an anion gap of 10 mEq/L10 \text{ mEq/L}, and a venous pH of 7.347.34. The physician determines the patient is ready to transition to a subcutaneous insulin regimen. Arrange the following steps in the correct chronological sequence to safely de-escalate therapy and establish ongoing monitoring.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient from an intravenous insulin infusion to subcutaneous insulin involves first verifying DKA resolution, followed by administering subcutaneous insulin, overlapping the intravenous infusion for 1 to 2 hours, discontinuing the intravenous infusion, and finally transferring the patient for routine ward monitoring.
The successful transition from intravenous to subcutaneous insulin requires careful sequencing to prevent relapse into diabetic ketoacidosis (DKA). First, objective resolution of DKA (closed anion gap, normalized pH) and clinical stability (ability to eat) must be confirmed. Next, subcutaneous basal and prandial insulin is administered. Because subcutaneous insulin has a delayed onset of action, the continuous intravenous insulin infusion must be maintained for a 1- to 2-hour overlap period. Discontinuing the infusion too early creates a dangerous window of absolute insulin deficiency, leading to rapid lipolysis, ketogenesis, and rebound DKA. Once the overlap period is complete, the intravenous infusion is stopped, and the patient is stepped down to a medical ward with routine glucose monitoring to evaluate the new regimen.

Step-by-Step Solution

1
Verify DKA resolution criteria.
The anion gap is closed (10 mEq/L10 \text{ mEq/L}) and the patient can tolerate a meal.
Ensures physiological stability and safe conditions for step-down therapy.
2
Administer subcutaneous insulin.
Patient receives a dose of basal and prandial insulin.
Initiates long-acting coverage and mealtime glycemic control.
3
Overlap therapies.
Intravenous insulin is maintained for 1 to 2 hours.
Allows adequate time for the subcutaneous insulin to absorb and reach therapeutic systemic levels.
4
Discontinue intravenous insulin.
The continuous infusion is turned off.
Completes the transition safely without causing rebound hyperglycemia.
5
Establish ongoing monitoring.
Glucose checks are scheduled regularly on the medical ward.
Evaluates the adequacy of the new regimen in a lower-acuity setting.

Key Concept

To prevent rebound diabetic ketoacidosis during the transition to subcutaneous insulin, a 1- to 2-hour overlap with the intravenous insulin infusion is mandatory after the first subcutaneous injection.
Question 1266Question →

A 75-year-old woman is evaluated on hospital day 6 for discharge planning following an emergency exploratory laparotomy for a perforated diverticulum. On admission, she presented with septic shock; her Sequential Organ Failure Assessment (SOFA) score was 7, and she required mechanical ventilation and vasopressor support in the intensive care unit (ICU) for 48 hours.

Currently, she is on a general surgical floor and is medically stable. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 122/76 mmHg122/76\text{ mmHg}, pulse 78/min78/\text{min}, and respiratory rate 16/min16/\text{min}. Her bowel function has returned, she is tolerating a soft diet, and her surgical incision is clean and intact. She has been transitioned to oral antibiotics.

A physical therapy evaluation reveals profound ICU-acquired weakness. She requires maximum assistance for bed-to-chair transfers and is currently unable to ambulate. She is highly motivated to recover but experiences severe fatigue, tolerating a maximum of 30 to 45 minutes of physical and occupational therapy daily. Prior to admission, she was fully independent with all activities of daily living. She lives with her 77-year-old husband in a single-level home; he works part-time during the day and has a history of severe osteoarthritis.

Based on her clinical severity history and current functional capacity, which of the following is the most appropriate discharge disposition?

Show answer & explanation

Answer: Transfer to a skilled nursing facility

Answer

Transfer to a skilled nursing facility
The correct disposition is a transfer to a skilled nursing facility (SNF). This patient is medically stable following a severe critical illness but exhibits significant ICU-acquired weakness. She requires continued, daily skilled physical and occupational therapy. Because her endurance limits her to 30 to 45 minutes of therapy a day, she does not meet the strict criteria for an Inpatient Rehabilitation Facility (IRF), which requires participation in at least 3 hours of therapy daily. Furthermore, her home environment is unsafe for her current functional level; she requires maximum physical assistance, which her elderly husband cannot provide due to his own osteoarthritis and daytime employment. An SNF provides the appropriate level of short-term rehabilitation in a safe, 24-hour supervised setting.

Step-by-Step Solution

1
Assess the patient's medical stability and ongoing medical needs.
The patient is medically stable, tolerating a diet, taking oral antibiotics, and has normal vital signs. She no longer requires acute inpatient hospitalization or complex acute care (LTACH).
Establishing medical stability rules out the need for continued acute care or step-down levels of care.
2
Evaluate the patient's functional capacity and rehabilitation endurance.
The patient has severe functional deficits (max assist for transfers) but limited endurance (can only tolerate 30 to 45 minutes of therapy daily).
Endurance directly dictates post-acute facility qualification. An endurance of <3< 3 hours daily eliminates the Inpatient Rehabilitation Facility (IRF) option.
3
Analyze the safety and support system of the home environment.
The husband has severe osteoarthritis and is absent during the day, meaning he cannot safely provide the maximum physical assistance she requires for mobility and transfers.
An unsafe home environment lacking 24/7 caregiving support eliminates the option of discharging home with intermittent home health services.
4
Synthesize the findings to select the optimal disposition.
A Skilled Nursing Facility (SNF) is selected.
An SNF provides the required daily skilled nursing and rehabilitation at a tolerable pace (<3< 3 hours/day) in a safe, 24-hour supervised environment until the patient regains enough strength to transition home.

Key Concept

Post-acute care disposition requires matching a patient's medical stability, functional endurance, and home support to specific facility criteria. A Skilled Nursing Facility (SNF) is indicated for patients needing short-term daily skilled therapy who lack the physical endurance for the 3-hour minimum daily therapy requirement of an Inpatient Rehabilitation Facility (IRF).
Estimated Time:1m 30s
Question 1267Question →

A 65-year-old man is hospitalized for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia secondary to an infected central venous catheter. The catheter was removed, and he was started on intravenous vancomycin 4 days ago. His clinical status has significantly improved, with resolution of fever and two consecutive sets of negative blood cultures. Today, routine laboratory studies show a serum creatinine level of 2.1 mg/dL, representing a significant increase from his baseline of 1.0 mg/dL on admission. His urine output over the past 24 hours has been 600 mL. A serum vancomycin trough level obtained 30 minutes before the next scheduled dose is 29 mcg/mL (therapeutic target for severe infections: 15-20 mcg/mL). Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Show answer & explanation

Answer: Withhold the scheduled vancomycin dose, check daily serum trough levels, and resume therapy at an adjusted dose once the level reaches the therapeutic target.

Answer

The correct action is to withhold the scheduled vancomycin dose, monitor daily serum trough levels, and resume therapy at an adjusted dose once the level reaches the therapeutic target.
The patient has developed acute kidney injury (AKI) secondary to vancomycin toxicity, evidenced by a rise in serum creatinine and a supratherapeutic trough level of 29 mcg/mL. The most appropriate management is to withhold further doses of vancomycin, monitor serum levels daily, and resume therapy at a lower dose or extended interval once the level falls back into the therapeutic range (15-20 mcg/mL). This prevents further nephrotoxicity while ensuring the patient eventually receives adequate antimicrobial coverage for their MRSA bacteremia.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient has developed acute kidney injury (AKI) in the setting of a supratherapeutic vancomycin trough level (29 mcg/mL).
Recognizing the correlation between the rising creatinine and the high drug level is essential to identify the etiology of the renal failure.
2
Determine the optimal immediate intervention.
The most pressing need is to prevent further nephrotoxicity by stopping the offending agent.
Vancomycin causes dose-dependent intrinsic renal damage; adding more drug, even at a reduced dose, will worsen the AKI.
3
Formulate an ongoing monitoring and treatment plan.
Serial vancomycin levels must be drawn until the trough falls into the target range (15-20 mcg/mL), at which point therapy can be safely resumed at a lower dose or extended interval.
The patient still requires treatment for MRSA bacteremia, and vancomycin remains an effective first-line option once the toxicity is managed.

Key Concept

Management of vancomycin-induced nephrotoxicity requires holding the medication, monitoring serial trough levels, and adjusting the dosing regimen once the drug level falls back into the therapeutic range.
Question 1268Question →

You are evaluating several patients in an outpatient primary care setting to update their preventive care plans. Based on current United States Preventive Services Task Force (USPSTF) guidelines, match each patient profile to the most appropriate evidence-based screening intervention that is newly indicated or essential for their specific clinical scenario.

Click a left item, then click its matching right item

Items

A 29-year-old primigravida at 10 weeks of gestation who has no significant medical history and reports a monogamous relationship.
A 55-year-old construction worker with a 25-pack-year smoking history who continues to smoke half a pack of cigarettes daily.
A 42-year-old accountant with a body mass index of 33 kg/m233 \text{ kg/m}^2 and a blood pressure of 134/86 mmHg134/86 \text{ mmHg} who is here for an annual checkup.
A 67-year-old retired teacher who smoked a pack of cigarettes daily for four years in college but has maintained strict abstinence since age 22.

Matches

Show answer & explanation

Answer

The correct matches align each patient with their highest-yield USPSTF-recommended screening based on age and risk factors: the pregnant patient with asymptomatic bacteriuria screening, the current heavy smoker with lung cancer screening, the obese middle-aged female with diabetes screening, and the older male 'ever smoker' with AAA screening.
Each patient profile maps to a distinct USPSTF Grade A or B recommendation. Pregnant patients require urine cultures for asymptomatic bacteriuria at their first prenatal visit. Adults aged 50-80 with a 20+ pack-year history require annual LDCT. Adults aged 35-70 who are overweight or obese require blood glucose screening. Men aged 65-75 who have 'ever smoked' (>100 cigarettes lifetime) require one-time AAA screening via ultrasound.

Step-by-Step Solution

1
Evaluate the pregnant patient (Left 1).
Identify that early pregnancy requires specific Grade A screenings, including checking for asymptomatic bacteriuria using a urine culture.
Untreated asymptomatic bacteriuria in pregnancy can rapidly progress to pyelonephritis.
2
Evaluate the 55-year-old current smoker (Left 2).
Identify that his age (50-80) and 25-pack-year history meet criteria for annual low-dose computed tomography.
LDCT is the only recommended screening modality for reducing lung cancer mortality in high-risk populations.
3
Evaluate the 42-year-old female with obesity (Left 3).
Identify that her age (35-70) and BMI (>25 kg/m2\text{kg/m}^2) meet criteria for diabetes and prediabetes screening.
Early detection of abnormal blood glucose allows for lifestyle interventions to prevent long-term cardiovascular and microvascular complications.
4
Evaluate the 67-year-old male former smoker (Left 4).
Identify that his age (65-75), biological sex (male), and history of smoking >100 cigarettes meet criteria for one-time abdominal aortic aneurysm screening.
AAA screening is indicated for any male who has 'ever smoked', defined as at least 100 cigarettes over their lifetime, regardless of when they quit.

Key Concept

Application of age-, sex-, and risk-specific USPSTF guidelines for preventive screening in the ambulatory setting.
Question 1269Question →

A 78-year-old woman is brought to the geriatrics clinic by her daughter due to a 2-week history of worsening confusion, daytime lethargy, and a recent mechanical fall at home. The daughter reports that the patient has been increasingly forgetful, occasionally experiencing visual hallucinations, and complaining of a severely dry mouth. Her medical history is significant for painful diabetic neuropathy, overactive bladder, type 2 diabetes mellitus, hypertension, and osteoarthritis of the knees.

Her current medications include:
- Amitriptyline 50 mg daily
- Oxybutynin 5 mg three times daily
- Zolpidem 5 mg at bedtime
- Metformin 1000 mg twice daily
- Lisinopril 10 mg daily

Vital signs:
- Temperature: 37.0°C (98.6°F)
- Blood pressure: 138/84 mmHg (supine), 125/78 mmHg (standing)
- Heart rate: 82/min
- Respiratory rate: 14/min

Laboratory results:
- Sodium: 139 mEq/L
- Potassium: 4.7 mEq/L
- Blood urea nitrogen: 24 mg/dL
- Creatinine: 1.2 mg/dL (baseline 1.1 mg/dL)
- Glucose: 145 mg/dL

Physical examination reveals a frail woman who is disoriented to time and date. Mucous membranes are exceedingly dry. There are no focal neurologic deficits.

Which of the following medications should be immediately discontinued to resolve this patient's current presentation? (Select 3)

Select all that apply

Show answer & explanation

Answer: Amitriptyline; Oxybutynin; Zolpidem

Answer

The correct medications to discontinue are amitriptyline, oxybutynin, and zolpidem.
The correct interventions involve discontinuing the specific medications that are directly contributing to this patient's anticholinergic toxidrome (dry mouth, visual hallucinations, confusion) and her increased fall risk. Amitriptyline and oxybutynin both possess potent antimuscarinic properties; when used together, they create a massive, synergistic anticholinergic burden that easily precipitates delirium in older adults. Furthermore, amitriptyline causes alpha-1 blockade, contributing to her orthostatic hypotension. Zolpidem is a sedative-hypnotic that independently increases the risk of cognitive impairment, daytime lethargy, and mechanical falls. All three of these medications appear on the AGS Beers Criteria and must be targeted for immediate deprescribing.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and physical examination.
The patient exhibits classic signs of an anticholinergic toxidrome (delirium, visual hallucinations, dry mucous membranes) alongside orthostatic hypotension and a recent mechanical fall.
Identifying the specific toxidrome and adverse events provides a framework for evaluating the patient's medication list.
2
Review the medication list against the American Geriatrics Society (AGS) Beers Criteria.
Amitriptyline, oxybutynin, and zolpidem are identified as potentially inappropriate medications for older adults due to their adverse effect profiles.
These drugs possess strong anticholinergic properties (amitriptyline, oxybutynin) or direct sedating and fall-inducing properties (zolpidem).
3
Evaluate the laboratory results to determine if other medications require discontinuation.
The mildly elevated creatinine (1.2 mg/dL) does not mandate the cessation of metformin or lisinopril, as there is no evidence of severe acute kidney injury or profound electrolyte derangement.
Ensures that essential chronic disease medications are not inappropriately stopped based on mild, stable laboratory variations.
4
Select the interventions that directly address the etiology of the patient's acute decline.
Amitriptyline, oxybutynin, and zolpidem must be immediately discontinued.
Removing the offending synergistic pharmacologic agents is the definitive treatment for medication-induced delirium and fall risk in the elderly.

Key Concept

Medication reconciliation and deprescribing of high-risk drugs (Beers Criteria) are essential to resolving medication-induced delirium and preventing falls in older adults.
Estimated Time:1m 30s
Question 1270Question →

A 7373-year-old woman is brought to the emergency department by her daughter after suddenly developing agonizing abdominal pain 44 hours ago. The patient has a history of ischemic cardiomyopathy, atrial fibrillation, and hypertension. She was prescribed warfarin but stopped taking it two weeks ago due to financial difficulties.

Vital signs are temperature 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure 82/50 mm Hg82/50\text{ mm Hg}, pulse 135/min135/\text{min} and irregularly irregular, and respirations 26/min26/\text{min}. Physical examination reveals a distended abdomen with diffuse, severe tenderness, involuntary guarding, and rebound tenderness. Bowel sounds are absent.

Laboratory studies show a leukocyte count of 22,000/mm322,000/\text{mm}^3 and a serum lactate level of 8.1 mmol/L8.1\text{ mmol/L}. Computed tomography angiography (CTA) of the abdomen reveals a complete occlusion of the proximal superior mesenteric artery. Air is visible within the bowel wall (pneumatosis intestinalis) and in the portal venous system.

Intravenous fluid resuscitation, broad-spectrum antibiotics, and an unfractionated heparin infusion are immediately initiated.

Which of the following is the most appropriate next step in the surgical management of this patient?

Show answer & explanation

Answer: Emergent exploratory laparotomy

Answer

The correct answer is emergent exploratory laparotomy.
The correct intervention is emergent exploratory laparotomy. This patient presents with advanced acute mesenteric ischemia complicated by irreversible bowel infarction, as evidenced by frank peritonitis, profound lactic acidosis, and pneumatosis intestinalis. In this scenario, the immediate surgical priority is two-fold: restoring blood flow and resecting all necrotic bowel to achieve source control. Only an open exploratory laparotomy provides the adequate exposure necessary to thoroughly run the entire length of the bowel, accurately delineate viable from non-viable segments, perform the necessary resections, and execute open surgical revascularization (e.g., embolectomy).

Step-by-Step Solution

1
Identify the primary diagnosis from the clinical presentation and imaging.
The patient has acute mesenteric ischemia due to an embolic superior mesenteric artery occlusion, heavily supported by her history of untreated atrial fibrillation.
Sudden-onset severe pain out of proportion to early exam findings, combined with CTA results, confirms the diagnosis.
2
Evaluate for the presence of irreversible bowel injury, infarction, or necrosis.
Bowel infarction has already occurred, indicated by overt peritonitis (guarding, rebound), severe lactic acidosis (8.1 mmol/L8.1\text{ mmol/L}), and pneumatosis intestinalis on CTA.
Recognizing tissue necrosis is the critical branch point in managing mesenteric ischemia, as it changes the required intervention.
3
Determine the most appropriate procedural intervention based on bowel viability.
Emergent exploratory laparotomy is required over minimally invasive techniques.
When necrotic bowel is present, open surgical exploration is mandatory to physically resect the non-viable segments and restore perfusion to the remaining healthy bowel. Endovascular approaches cannot address the dead tissue.

Key Concept

In patients with acute mesenteric ischemia, the presence of peritonitis, hemodynamic instability, or radiographic signs of bowel infarction (such as pneumatosis intestinalis) constitutes an absolute indication for emergent exploratory laparotomy rather than endovascular intervention.
Question 1271Question →

A 52-year-old female presents to the emergency department with a subjective fever and mild fatigue that started 12 hours ago. She is currently undergoing adjuvant chemotherapy (docetaxel and cyclophosphamide) for early-stage breast cancer, with her last cycle administered 10 days ago. Her temperature is 38.5∘C38.5^\circ\text{C} (101.3∘F101.3^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, pulse is 86/min86/\text{min}, and respirations are 14/min14/\text{min}. Pulse oximetry is 99%99\% on room air. Physical examination reveals a well-appearing woman who is alert and oriented. There is no focal source of infection; her lungs are clear, and there is no erythema at her port-a-cath site or signs of mucositis. Laboratory results show a white blood cell count of 800/mm3800/\text{mm}^3 with an absolute neutrophil count (ANC) of 350/mm3350/\text{mm}^3. Her hemoglobin is 10.5 g/dL10.5\text{ g/dL}, platelets are 110,000/mm3110,000/\text{mm}^3, and creatinine is 0.8 mg/dL0.8\text{ mg/dL}. Blood cultures are drawn. Her Multinational Association for Supportive Care in Cancer (MASCC) risk index score is calculated to be 25. The patient is functionally independent, tolerates oral intake without nausea, and lives with her highly supportive husband in a home located 15 minutes from the hospital with reliable transportation. Based on her clinical status and objective severity scoring, which of the following is the most appropriate disposition and initial management plan?

Show answer & explanation

Answer: Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate, and arrange 24-hour outpatient follow-up.

Answer

Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate, and arrange 24-hour outpatient follow-up.
This patient presents with febrile neutropenia, an oncologic emergency requiring prompt empiric antibiotic therapy. However, disposition relies on careful risk stratification. The Multinational Association for Supportive Care in Cancer (MASCC) risk index is a validated tool used to identify low-risk patients. A MASCC score of ≥21\ge 21 indicates a low risk of severe complications. This patient has a score of 25. Furthermore, she meets all necessary functional and social criteria for a safe care transition: she is hemodynamically stable, lacks organ dysfunction, tolerates oral intake (making oral antibiotics feasible), and has excellent home support with proximity to the hospital. In such cases, the evidence-based standard of care is to discharge the patient home with a prescription for broad-spectrum oral antibiotics (typically a fluoroquinolone such as ciprofloxacin combined with amoxicillin-clavulanate) and ensure strict 24-hour outpatient follow-up.

Step-by-Step Solution

1
Identify the patient's condition as acute febrile neutropenia based on fever (38.5∘C38.5^\circ\text{C}) and an absolute neutrophil count <500/mm3< 500/\text{mm}^3.
The patient has a potentially life-threatening oncologic emergency requiring immediate empiric antibiotics.
Establishing the primary diagnosis dictates the specific risk stratification pathway required.
2
Assess the objective severity score using the provided MASCC risk index.
The patient's MASCC score is 25. A score of ≥21\ge 21 designates the patient as having a low risk for severe complications.
Objective severity scores are required to determine if a patient safely qualifies for outpatient versus inpatient management.
3
Evaluate the functional and social context to confirm whether a safe transition to home is feasible.
The patient tolerates oral fluids (essential for oral antibiotics), lives close to the hospital, has reliable transportation, and has excellent caregiver support.
Even with a low-risk score, patients lacking proper social support, telephone access, or the ability to take oral medications must be admitted.
4
Synthesize the clinical data to determine the optimal care setting transition.
The patient is eligible for direct discharge home from the ED with empiric oral antibiotics and a scheduled 24-hour follow-up.
This strategy avoids unnecessary hospital-acquired infections and optimizes resource utilization while ensuring patient safety.

Key Concept

Patients with low-risk febrile neutropenia (MASCC score >= 21) who have reliable social support and tolerate oral intake should be transitioned to home care with oral empiric antibiotics rather than admitted to the hospital.
Question 1272Question →

A 24-year-old male is evaluated in the orthopedic unit for severe left lower leg pain 12 hours after undergoing open reduction and internal fixation of a comminuted midshaft tibia fracture. He describes the pain as a "10/10" burning sensation that is significantly worse than his preoperative pain. The pain is not relieved by escalating doses of intravenous hydromorphone. On physical examination, the left lower leg is visibly swollen, and the skin is tense and shiny. Passive dorsiflexion of the toes elicits excruciating pain. Sensation to light touch is decreased over the first dorsal web space. Dorsalis pedis and posterior tibial pulses are equal and brisk. Which of the following are the most appropriate next steps in the management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Immediate removal of all encircling dressings and splints down to the skin; Emergent four-compartment fasciotomy of the affected extremity

Answer

The most appropriate next steps are the immediate removal of all encircling dressings and splints down to the skin, followed by an emergent four-compartment fasciotomy of the affected extremity.
This patient presents with classic signs of acute compartment syndrome (ACS) of the lower leg following a tibial fracture repair. The clinical hallmarks of ACS include pain out of proportion to the injury, pain exacerbated by passive stretch of the involved muscles, tense compartments, and paresthesias. Importantly, normal distal pulses are typically maintained until the very late stages of ischemia, as the pressure required to occlude capillary and venous flow is significantly lower than arterial systolic pressure. When ACS is clinically evident, management requires two immediate procedural interventions. First, any external compressive forces must be eliminated by completely removing dressings, bivalving casts, and cutting padding down to the skin. This simple maneuver can reduce compartment pressure significantly. Second, because the patient has unequivocal signs of ACS including a focal neurological deficit (deep peroneal nerve territory), definitive treatment requires emergent surgical decompression via a four-compartment fasciotomy.

Step-by-Step Solution

1
Analyze the clinical presentation
The patient has severe pain out of proportion to injury, pain with passive stretch, tense leg swelling, and paresthesias (decreased sensation in the first web space) following a high-risk tibia fracture.
These findings are the classic clinical hallmarks of acute compartment syndrome.
2
Interpret the presence of distal pulses
Dorsalis pedis and posterior tibial pulses are present.
Palpable pulses do not rule out compartment syndrome, because microvascular capillary bed occlusion occurs at much lower pressures than major arterial occlusion.
3
Determine the necessary initial and definitive interventions
First, remove external compression. Second, perform surgical decompression.
Bivalving casts and removing dressings can drop compartment pressure by up to 85%. Since the patient has an unequivocal clinical presentation with neurologic deficits, emergent fasciotomy is definitively required without delay.

Key Concept

Acute compartment syndrome is a surgical emergency diagnosed clinically by pain out of proportion to injury, pain on passive stretch, and tense compartments. Management requires immediate removal of external constraints and emergent surgical fasciotomy, strictly avoiding limb elevation.
Question 1273Question →

A 61-year-old man presents to the primary care clinic for a follow-up visit. Three weeks ago, he was diagnosed with active pulmonary tuberculosis and started on a regimen of rifampin, isoniazid, pyrazinamide, and ethambutol. Two days ago, he presented to an urgent care clinic with palpitations and was diagnosed with new-onset atrial fibrillation. His past medical history is significant for hypertension, type 2 diabetes mellitus, and heart failure with preserved ejection fraction. Based on a CHA2DS2-VASc score of 4, the urgent care physician initiated apixaban and metoprolol. The patient reports that his palpitations have resolved, and he has not experienced any bleeding, bruising, or neurologic symptoms. His temperature is 37.1°C (98.8°F), blood pressure is 126/78 mmHg, and pulse is 76/min and irregularly irregular. Cardiopulmonary examination is otherwise unremarkable. Which of the following is the most appropriate modification to this patient's pharmacotherapy?

Show answer & explanation

Answer: Change apixaban to warfarin

Answer

Change apixaban to warfarin
The correct answer is to switch the direct oral anticoagulant (DOAC) to a vitamin K antagonist. The patient has a high risk of thromboembolism from atrial fibrillation (CHA2DS2-VASc score of 4) and requires systemic anticoagulation. He was recently started on apixaban, a DOAC. However, he is also taking rifampin for active pulmonary tuberculosis. Rifampin is a potent inducer of both cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp). Apixaban is a substrate for both CYP3A4 and P-gp. Co-administration of strong CYP3A4 and P-gp inducers like rifampin significantly decreases the plasma concentration of apixaban, thereby compromising its efficacy and increasing the risk of stroke. As a result, the concurrent use of apixaban and rifampin is contraindicated. To provide effective anticoagulation, the patient should be switched to a medication whose efficacy can be monitored and dose-adjusted. Warfarin is metabolized by CYP enzymes, and its metabolism is also induced by rifampin. However, the dose of warfarin can be easily titrated to achieve a therapeutic International Normalized Ratio (INR), making it the preferred oral anticoagulant for patients requiring concurrent rifampin therapy.

Step-by-Step Solution

1
Analyze the patient's current medication list and new diagnosis.
The patient is taking rifampin for tuberculosis and apixaban for new-onset atrial fibrillation.
Identifying concurrent medications is essential for preventing adverse drug events.
2
Identify potential pharmacokinetic interactions between the medications.
Rifampin is a strong inducer of CYP3A4 and P-glycoprotein (P-gp), while apixaban is a substrate for both.
Strong inducers increase the clearance of substrates, leading to subtherapeutic drug levels.
3
Determine the most appropriate alternative therapy for stroke prevention.
Warfarin should be selected over DOACs because its dose can be titrated and monitored using the INR.
Unlike DOACs, warfarin therapy allows for objective measurement of the anticoagulant effect despite concurrent enzyme induction.

Key Concept

Management of pharmacokinetic interactions involving direct oral anticoagulants (DOACs) and potent CYP3A4/P-gp inducers.
Question 1274Question →

An ambulatory infectious disease clinic evaluates a 45-year-old male patient who recently received a diagnosis of active cavitary pulmonary tuberculosis. His initial sputum acid-fast bacilli (AFB) smear is positive, and rapid molecular testing has confirmed the presence of a pan-susceptible Mycobacterium tuberculosis isolate. As he prepares to commence standard antituberculous pharmacotherapy, the clinical team formulates his longitudinal care plan.

Arrange the following steps representing the appropriate monitoring and treatment evaluation protocol for this patient in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first perform baseline testing, then transition to a two-drug phase at exactly 8 weeks, subsequently review the finalized 8-week culture, extend the continuation phase based on that delayed result, and finally verify treatment completion at 9 months.
The chronological sequence for monitoring and treating cavitary pulmonary tuberculosis follows a strict protocol. Baseline safety labs and visual acuity testing must be obtained before initiating therapy. At exactly 8 weeks, the intensive phase concludes, and therapy is de-escalated to a two-drug continuation phase (assuming pan-susceptibility). Because mycobacterial cultures take several weeks to grow, the finalized results of the 8-week sputum culture are reviewed after the patient has already entered the continuation phase. Upon discovering that this 8-week culture remains positive in a patient with cavitary disease, treatment evaluation protocols require extending the continuation phase from 4 months to 7 months. Finally, clinical resolution is verified at the end of the newly adjusted 9-month course.

Step-by-Step Solution

1
Perform baseline visual acuity testing and a hepatic function panel before initiating the four-drug intensive regimen.
Baseline clinical and safety parameters are established prior to drug exposure.
Monitoring for ethambutol-induced optic neuropathy and medication-induced hepatotoxicity requires baseline comparative values.
2
Transition to a two-drug continuation phase with isoniazid and rifampin upon completing 8 weeks of intensive therapy.
The patient successfully completes the intensive phase and appropriately de-escalates to standard continuation therapy.
The intensive phase is fixed at 8 weeks; de-escalation occurs immediately at this mark when susceptibility is known, without delaying for culture results.
3
Review the finalized 8-week follow-up sputum culture, which demonstrates persistent growth of Mycobacterium tuberculosis.
Delayed microbiologic clearance is officially identified.
Cultures drawn at the 8-week mark take several weeks to finalize and are inherently reviewed during the initial portion of the continuation phase.
4
Extend the planned two-drug continuation phase from 4 months to 7 months due to delayed microbiologic clearance.
The total treatment duration is adjusted from 6 months to 9 months.
Patients with cavitary lung disease and a positive 2-month culture have a substantially higher risk of relapse and require a 7-month continuation phase.
5
Assess for treatment completion and verify clinical resolution at the conclusion of the 9-month total therapy course.
Antituberculous therapy is officially concluded.
Final evaluation ensures all extended doses were successfully taken and the patient is clinically cured prior to discharge from the clinic.

Key Concept

The standard monitoring protocol for cavitary pulmonary tuberculosis involves an 8-week intensive phase, transition to a continuation phase, and subsequent retrospective evaluation of 2-month culture results to determine if the treatment duration must be extended from 6 to 9 months.
Estimated Time:1m 30s
Question 1275Question →

A 42-year-old woman is undergoing an elective laparoscopic cholecystectomy for recurrent biliary colic. During the dissection of Calot's triangle, a sudden, brisk, pulsatile hemorrhage occurs, rapidly pooling and obscuring the operative field. The operating surgeon is unable to adequately visualize or isolate the source of the bleeding using the laparoscope despite aggressive suctioning.

Which of the following procedural interventions are indicated immediately? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Conversion to an open laparotomy; Application of direct pressure to the bleeding area with a laparoscopic sponge

Answer

The correct immediate interventions are the application of direct pressure to the bleeding area with a laparoscopic sponge and prompt conversion to an open laparotomy.
In the event of massive, uncontrolled bleeding during a laparoscopic procedure where the source cannot be clearly visualized, the immediate priority is to achieve temporary hemostasis and secure adequate surgical exposure. Applying direct pressure with a laparoscopic sponge provides essential temporary control of the hemorrhage. Concurrently, the procedure must be converted to an open laparotomy to allow for direct visualization, proximal and distal control of the vessels, and safe definitive repair. These steps prevent exsanguination and minimize the risk of iatrogenic injury to surrounding critical structures in Calot's triangle.

Step-by-Step Solution

1
Recognize a life-threatening intraoperative hemorrhage that cannot be controlled or visualized via laparoscopy.
Determination that the current minimally invasive approach is no longer safe.
Continuing laparoscopically without visualization risks catastrophic exsanguination or iatrogenic injury.
2
Apply immediate temporary hemostasis using direct pressure with a laparoscopic sponge.
The rate of hemorrhage is temporarily slowed.
Temporizing the bleed allows the anesthesiologist to stabilize the patient's hemodynamics while the surgical team prepares for the next step.
3
Convert the procedure to an open laparotomy (typically via a right subcostal incision).
The surgeon gains direct manual access and wide visualization of the right upper quadrant.
Direct visualization is strictly required to identify the specific bleeding vessel (e.g., cystic artery avulsion or right hepatic artery injury) and safely achieve definitive ligation.

Key Concept

Management of uncontrolled hemorrhage during laparoscopic surgery
Question 1276Question →

Paramedics arrive at the resuscitation bay with a 61-year-old male who developed crushing, substernal chest pressure radiating to his jaw two hours ago while gardening. He reports severe lightheadedness and nausea. Past medical history is significant for hyperlipidemia and osteoarthritis.

Upon arrival, his temperature is 37.0°C (98.6°F), blood pressure is 74/48 mmHg, heart rate is 52/min, and respiratory rate is 16/min. Oxygen saturation is 96% on room air.

Physical examination reveals a pale, diaphoretic patient. The jugular veins are markedly distended while the patient is sitting at a 45-degree angle. Auscultation of the chest reveals clear breath sounds bilaterally without wheezes or crackles. Heart sounds are distant, and no murmurs are appreciated.

A 12-lead electrocardiogram obtained by triage staff demonstrates 3-mm ST-segment elevations in leads II, III, and aVF, along with reciprocal ST-segment depressions in leads I and aVL.

Which of the following is the most appropriate next step in the initial stabilization of this patient?

Show answer & explanation

Answer: Administration of an isotonic intravenous fluid bolus

Answer

Administration of an isotonic intravenous fluid bolus
The patient is experiencing profound hypotension due to an acute right ventricular (RV) myocardial infarction. This diagnosis is supported by the classic triad of hypotension, elevated jugular venous pressure (JVD), and clear lung fields, occurring alongside an inferior STEMI (ST elevations in II, III, aVF). The ischemic right ventricle becomes stiff and loses its contractile function, making it highly dependent on elevated preload to maintain blood flow to the left ventricle. Therefore, the most critical initial stabilization step is volume expansion with an isotonic intravenous fluid bolus (e.g., normal saline) to increase RV filling pressures and subsequently improve systemic cardiac output.

Step-by-Step Solution

1
Analyze the clinical presentation and vital signs.
The patient has severe hypotension, bradycardia, clear lung fields, and jugular venous distention in the context of an acute ischemic event.
Identifying the specific hemodynamic state is required before intervening.
2
Interpret the electrocardiogram findings.
ST elevations in leads II, III, and aVF indicate an acute inferior myocardial infarction.
Inferior myocardial infarctions frequently involve the right ventricle, altering the standard acute coronary syndrome management pathway.
3
Synthesize findings to determine the underlying pathophysiology.
The triad of hypotension, clear lungs, and jugular venous distention in the setting of an inferior myocardial infarction is highly specific for a right ventricular infarction.
Right ventricular ischemia leads to a stiff right ventricle that relies on high preload to push blood into the pulmonary circulation and subsequently to the left ventricle.
4
Select the most appropriate initial stabilization step.
Administer isotonic intravenous fluids to maximize preload and optimize cardiac output.
Fluid resuscitation directly addresses the preload-dependent state causing the patient's profound hypotension.

Key Concept

Right ventricular myocardial infarction presents with hypotension, elevated jugular venous pressure, and clear lungs, and requires immediate stabilization with isotonic intravenous fluids to maintain adequate preload.
Question 1277Question →

A 61-year-old man visits his primary care provider to establish care and review his preventive health needs. His past medical history is significant for essential hypertension and hyperlipidemia. He currently smokes one pack of cigarettes daily and has done so for the past 30 years (30 pack-year history). His current medications include amlodipine and atorvastatin. A review of his medical records shows that he had a normal screening colonoscopy 6 years ago. He completed the recombinant zoster vaccine series at age 55 and received the current seasonal influenza vaccine at a local pharmacy last month. He denies any chest pain, shortness of breath, cough, or changes in bowel habits. Which of the following preventive interventions are indicated for this patient at this visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Low-dose computed tomography of the chest; 20-valent pneumococcal conjugate vaccine

Answer

The indicated interventions are low-dose computed tomography of the chest and the 20-valent pneumococcal conjugate vaccine.
The correct interventions are low-dose computed tomography (LDCT) of the chest and the 20-valent pneumococcal conjugate vaccine. The patient meets the USPSTF criteria for annual LDCT screening because he is between the ages of 50 and 80, has a smoking history of at least 20 pack-years, and is a current smoker. Additionally, current cigarette smoking is an indication for pneumococcal vaccination in adults aged 19 to 64 years, as it significantly increases the risk of invasive pneumococcal disease.

Step-by-Step Solution

1
Evaluate the patient's age and smoking history to determine lung cancer screening eligibility.
The patient is 61 years old with a 30 pack-year smoking history and currently smokes. He meets criteria for annual low-dose computed tomography (LDCT).
Guidelines recommend LDCT for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or quit within the last 15 years.
2
Assess the patient's vaccination history and risk factors.
The patient has a history of smoking, which is a qualifying condition for pneumococcal vaccination in adults under 65.
Cigarette smoking compromises respiratory defenses, placing the patient at higher risk for invasive pneumococcal disease.
3
Review the patient's prior screening for colorectal cancer.
The patient had a normal colonoscopy 6 years ago. The next screening is not due for another 4 years.
A normal colonoscopy provides a 10-year screening interval, during which interim testing with other modalities is not recommended.
4
Consider other age-based screening guidelines for this male patient.
Abdominal aortic aneurysm screening and osteoporosis screening are not indicated.
AAA screening begins at age 65 for men who have ever smoked. Routine DEXA scans are generally reserved for women aged 65 and older or those at elevated risk.

Key Concept

Age and risk-factor specific preventive screening guidelines
Question 1278Question →

A 38-year-old woman presents to the urgent care clinic with a 3-day history of extreme fatigue, sore throat, and new-onset bleeding from her gums while brushing her teeth. She has a history of severe Crohn disease that has been well-controlled on daily azathioprine for the past three years. Three weeks ago, she developed a painful, swollen right great toe and was diagnosed with a gout flare. Her primary care physician started her on allopurinol to prevent future attacks. Her temperature is 38.4°C (101.1°F), blood pressure is 112/72 mm Hg, and pulse is 108/min. Physical examination reveals mucosal pallor, oral petechiae, and pharyngeal erythema without exudate. Which of the following is the most appropriate next step in the evaluation and management of this patient?

Show answer & explanation

Answer: Withhold azathioprine and allopurinol, and immediately obtain a complete blood count.

Answer

Withhold azathioprine and allopurinol, and immediately obtain a complete blood count.
The correct answer addresses the critical and potentially fatal drug-drug interaction between azathioprine and allopurinol. Azathioprine is a prodrug that is converted to 6-mercaptopurine (6-MP). 6-MP is subsequently metabolized and inactivated by the enzyme xanthine oxidase. Allopurinol, prescribed for the patient's gout, is a potent xanthine oxidase inhibitor. Coadministration of these two drugs causes a profound decrease in the metabolism of 6-MP, leading to its toxic accumulation. This results in severe bone marrow suppression. The patient's presentation of fever, sore throat, severe fatigue, pallor, and petechiae is the classic triad of pancytopenia: neutropenia, anemia, and thrombocytopenia, respectively. The most appropriate initial step is to immediately withhold both medications and obtain a complete blood count to evaluate the severity of the bone marrow failure.

Step-by-Step Solution

1
Identify the critical drug interaction in the patient's medication history.
The patient is taking both azathioprine and allopurinol.
Azathioprine is converted to 6-mercaptopurine, which is metabolized by xanthine oxidase. Allopurinol inhibits xanthine oxidase, leading to a toxic accumulation of 6-mercaptopurine.
2
Correlate the drug interaction with the patient's physical symptoms.
Fever, sore throat, mucosal pallor, and petechiae are identified as signs of pancytopenia.
The toxic accumulation of 6-mercaptopurine causes severe dose-dependent bone marrow suppression, manifesting as neutropenia (infection/fever), anemia (pallor/fatigue), and thrombocytopenia (petechiae/bleeding).
3
Determine the safest and most appropriate immediate clinical intervention.
The offending medications must be stopped and blood counts must be checked.
Immediate cessation prevents further toxicity, and a complete blood count is the definitive initial diagnostic test to quantify the severity of the myelosuppression.

Key Concept

Patients taking azathioprine or 6-mercaptopurine who are subsequently prescribed allopurinol are at high risk for life-threatening bone marrow suppression due to xanthine oxidase inhibition.
Question 1279Question →

A 52-year-old male who underwent a deceased-donor renal transplantation 8 months ago is evaluated in the inpatient medical ward for a 4-day history of fever, dry cough, and right-sided pleuritic chest pain. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. Temperature is 38.6°C (101.5°F), blood pressure is 132/82 mmHg, pulse is 108/min, and respirations are 20/min. Oxygen saturation is 93% on room air. Laboratory studies reveal a serum creatinine of 1.4 mg/dL (baseline 1.3 mg/dL). A non-contrast CT scan of the chest demonstrates a nodular consolidation with a surrounding ground-glass opacity (halo sign) in the right upper lobe. Bronchoscopy with bronchoalveolar lavage is performed, and galactomannan antigen testing is markedly positive. The infectious disease service recommends initiating intravenous voriconazole. Which of the following is the most appropriate pharmacologic intervention regarding this patient's current medication regimen?

Show answer & explanation

Answer: Decrease the tacrolimus dose and monitor serum trough levels

Answer

Decrease the tacrolimus dose and monitor serum trough levels
The correct intervention is to decrease the tacrolimus dose and closely monitor serum trough levels. Voriconazole, the first-line pharmacotherapy for invasive pulmonary aspergillosis, is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is a calcineurin inhibitor that relies heavily on CYP3A4 for its metabolism and clearance. Coadministration of these two agents without adjusting the baseline immunosuppressive regimen will rapidly lead to supratherapeutic tacrolimus levels. This significantly increases the risk of severe side effects, most notably acute nephrotoxicity, neurotoxicity (such as tremors or seizures), and over-immunosuppression. Standard clinical guidelines mandate reducing the tacrolimus dose—often by approximately one-third to one-half—when initiating voriconazole, followed by meticulous therapeutic drug monitoring.

Step-by-Step Solution

1
Identify the primary diagnosis and confirm the necessity of the recommended treatment.
The patient's clinical presentation, halo sign on CT, and markedly positive galactomannan antigen confirm invasive pulmonary aspergillosis, which necessitates treatment with voriconazole.
Establishing the correct therapeutic agent is required to evaluate potential drug-drug interactions with the patient's baseline regimen.
2
Analyze the pharmacokinetic properties of both the baseline immunosuppressants and the newly prescribed antifungal.
Voriconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is a calcineurin inhibitor heavily metabolized by CYP3A4.
Recognizing this specific enzyme interaction is critical to preventing iatrogenic toxicity.
3
Determine the appropriate dose adjustment strategy to mitigate the interaction.
The tacrolimus dose must be empirically reduced (typically by one-third to one-half) upon starting voriconazole, accompanied by close therapeutic drug monitoring.
Proactive dose reduction prevents supratherapeutic tacrolimus concentrations, which would otherwise lead to severe nephrotoxicity and neurotoxicity.

Key Concept

Initiation of voriconazole, a potent CYP3A4 inhibitor, in a patient taking tacrolimus requires a pre-emptive reduction in the tacrolimus dose and close therapeutic drug monitoring to prevent severe calcineurin inhibitor toxicity.
Question 1280Question →

A physician is evaluating a 67-year-old male patient who reports a nagging, dry cough persisting for three months. The patient, who has a 45-pack-year history of cigarette smoking, denies hemoptysis, night sweats, or unintentional weight loss. His past medical history includes essential hypertension and mild chronic obstructive pulmonary disease. Auscultation of the lungs reveals globally decreased breath sounds without focal adventitious sounds. An initial posteroanterior and lateral chest radiograph is obtained, revealing an incidental 2.2-cm, irregularly shaped, noncalcified density in the apical region of the right lung.

Arrange the following diagnostic interventions in the correct sequential order to properly work up this patient's pulmonary finding, beginning with the immediate next best step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence is to first review prior imaging, followed by a high-resolution CT of the chest, then a PET scan, and finally a tissue biopsy.
The correct sequence prioritizes minimizing patient risk and resource utilization while sequentially gathering diagnostic data. Reviewing prior imaging can immediately halt a costly workup if the lesion is stable. High-resolution CT provides the necessary anatomic detail to determine if a PET scan is warranted. A PET scan then provides metabolic data and staging information, which ultimately guides the safest and most accurate approach for the final, most invasive step: tissue biopsy.

Step-by-Step Solution

1
Determine the need for further imaging by establishing nodule stability over time.
Review of prior imaging is identified as the first step.
A nodule that has been stable in size for more than two years is almost always benign and requires no further invasive or radiating workup.
2
Characterize the nodule's detailed anatomy if prior imaging is unavailable or shows growth.
High-resolution CT is selected as the second step.
CT delineates morphology, calcification patterns, and regional anatomy with much higher fidelity than plain radiographs.
3
Assess the metabolic activity of the lesion and screen for occult metastases.
FDG-PET scan is selected as the third step.
PET guides staging and identifies the best target for biopsy in high-risk, solid nodules larger than 8 mm.
4
Obtain definitive histopathologic confirmation of the lesion.
Image-guided biopsy is the final step.
Invasive testing should only follow complete non-invasive staging, which dictates the safest and highest-yield approach.

Key Concept

The diagnostic sequencing of a newly discovered solitary pulmonary nodule prioritizes historical data first (prior imaging), followed by detailed anatomic characterization (high-resolution CT), metabolic assessment and staging (PET scan), and finally invasive tissue sampling (biopsy).
Estimated Time:1m 30s
PreviousPage 64 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 64 | Examkin